A correlation of APC and c-myc mRNA levels in lung cancer cell lines

被引:0
|
作者
Jaiswal, AS
Kennedy, CH
Narayan, S
机构
[1] Univ Texas, Med Branch, Sealy Ctr Oncol & Hematol, Galveston, TX 77555 USA
[2] Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA
[3] Louisiana State Univ, Inst Biodynam, Baton Rouge, LA 70803 USA
[4] Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA
关键词
adenomatous polyposis coli (APC); c-myc; mRNA; lung cancer cell lines;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
One of the functions of adenomatous polyposis coli (APC) in colorectal cancers is regulation of c-myc gene expression. However, the role of APC in lung cancers has not been elucidated. In the present study, the levels of APC and c-myc mRNA were determined in one strain of normal human bronchial epithelial (NHBE) cells, an SV-40-immortalized non-tumorigenic human bronchial epithelial cell line (BEAS-2B), 13 non-small cell lung cancer cell lines, and 4 small cell lung cancer cell lines. To establish a relationship between c-Myc and APC, we determined the ratio of c-myc and APC mRNA levels in different lung cancer cell lines. Out of 19 lung cancer cell lines, we found that 13 exhibited c-myc/APC mRNA ratio of more than two. Among the cell lines CaLu-3, NCI-H82, A427 and SW900 showed a very low level of APC mRNA and a high level of c-myc mRNA. The ratio of c-myc/APC mRNA in these cell lines was 48, 127, 325 and 708, respectively. The results of these analyses revealed an inverse relationship between APC and c-myc mRNA levels, suggesting that APC may regulate c-myc expression in lung cancer cells in a manner analogous to its role in colon cancer.
引用
收藏
页码:1253 / 1256
页数:4
相关论文
共 50 条
  • [1] c-Myc inhibition in prostate cancer cell lines
    Riveros, Carlos
    Chalfant, Victor
    Shukla, Sanjeev
    Osumi, Teruko
    Balaji, K. C.
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [2] LOCALIZATION OF AMPLIFIED C-MYC AND N-MYC IN SMALL CELL LUNG-CANCER CELL-LINES
    VANDERHOUT, AH
    KOK, K
    VANDERVEEN, AY
    OSINGA, J
    DELEIJ, LFMH
    BUYS, CHCM
    [J]. CANCER GENETICS AND CYTOGENETICS, 1989, 38 (01) : 1 - 8
  • [3] AMPLIFICATION AND EXPRESSION OF THE C-MYC ONCOGENE IN HUMAN-LUNG CANCER CELL-LINES
    LITTLE, CD
    NAU, MM
    CARNEY, DN
    GAZDAR, AF
    MINNA, JD
    [J]. NATURE, 1983, 306 (5939) : 194 - 196
  • [4] Statins decrease the expression of c-Myc protein in cancer cell lines
    Prema S. Rao
    U. Subrahmanyeswara Rao
    [J]. Molecular and Cellular Biochemistry, 2021, 476 : 743 - 755
  • [5] Statins decrease the expression of c-Myc protein in cancer cell lines
    Rao, Prema S.
    Rao, U. Subrahmanyeswara
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2021, 476 (02) : 743 - 755
  • [6] Comparison of c-Myc inhibitor effectiveness in various cancer cell lines
    Kuna, Marija
    Raucher, Drazen
    [J]. CANCER RESEARCH, 2015, 75
  • [7] TRANSFECTION OF THE C-MYC PROTO-ONCOGENE INTO CLASSIC SMALL CELL LUNG-CANCER (SCLC) CELL-LINES CAUSES PHENOTYPIC CHANGES ASSOCIATED WITH C-MYC AMPLIFIED VARIANT SCLC LINES
    JOHNSON, BE
    BATTEY, JF
    CARNEY, DC
    MINNA, JD
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 66 - 66
  • [8] C-MYC modulation induces responsiveness to paclitaxel in adrenocortical cancer cell lines
    Cerquetti, Lidia
    Sampaoli, Camilla
    De Salvo, Maria
    Bucci, Barbara
    Argese, Nicola
    Chimento, Adele
    Vottari, Sebastiano
    Marchese, Rodolfo
    Pezzi, Vincenzo
    Toscano, Vincenzo
    Stigliano, Antonio
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (05) : 2231 - 2240
  • [9] Identification of c-MYC as a target of the APC pathway
    He, TC
    Sparks, AB
    Rago, C
    Hermeking, H
    Zawel, L
    da Costa, LT
    Morin, PJ
    Vogelstein, B
    Kinzler, KW
    [J]. SCIENCE, 1998, 281 (5382) : 1509 - 1512
  • [10] The polyadenylation inhibitor cordycepin (3′dA) causes a decline in c-MYC mRNA levels without affecting c-MYC protein levels
    Ioannidis, P
    Courtis, N
    Havredaki, M
    Michailakis, E
    Tsiapalis, CM
    Trangas, T
    [J]. ONCOGENE, 1999, 18 (01) : 117 - 125